Neumora Therapeutics, Inc. (CIK: 0001885522) EDGAR, Information, Filings... CompaniesBIO.Com

Neumora Therapeutics, Inc.

Mailing address
490 ARSENAL WAY, SUITE 200, WATERTOWN, Delaware, 02472
Phone
(857) 760-0900
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Neumora Therapeutics, Inc. (CIK: 0001885522) is an American company incorporated in the state of Massachusetts. Head office is located at 490 ARSENAL WAY, SUITE 200, WATERTOWN, Massachusetts, 02472. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Neumora Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Neumora Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001610717-24-000478 ( Act) Size: 0 KB	Sep-16-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001610717-24-000475 ( Act) Size: 0 KB	Sep-13-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001964306-24-000357 (33 Act) Size: 0 KB	Sep-12-2024	001-41802 241295776
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001610717-24-000457 ( Act) Size: 0 KB	Aug-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001610717-24-000456 ( Act) Size: 0 KB	Aug-26-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0002002698-24-000259 (33 Act) Size: 0 KB	Aug-22-2024	001-41802 241230405
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-091737 (34 Act) Size: KB	Aug-06-2024	001-41802 241179008
8-K	Document	Current report filing Acc-no: 0000950170-24-091205 (34 Act) Size: KB	Aug-06-2024	001-41802 241177073
SCHEDULE 13G	Document	Acc-no: 0000315066-24-001797 (34 Act) Size: KB	Jul-08-2024	005-94162 241104907
SCHEDULE 13G	Document	Acc-no: 0000315066-24-001795 (34 Act) Size: KB	Jul-08-2024	005-94162 241104011
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001610717-24-000380 ( Act) Size: 0 KB	Jun-28-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001610717-24-000338 ( Act) Size: 0 KB	Jun-14-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001610717-24-000337 ( Act) Size: 0 KB	Jun-14-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001610717-24-000336 ( Act) Size: 0 KB	Jun-14-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001610717-24-000335 ( Act) Size: 0 KB	Jun-14-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001610717-24-000334 ( Act) Size: 0 KB	Jun-14-2024
8-K	Document	Current report filing Acc-no: 0001193125-24-161572 (34 Act) Size: KB	Jun-14-2024	001-41802 241044592
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-054448 (34 Act) Size: KB	May-07-2024	001-41802 24921653
8-K	Document	Current report filing Acc-no: 0000950170-24-053933 (34 Act) Size: KB	May-07-2024	001-41802 24919592
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950170-24-048333 (34 Act) Size: KB	Apr-25-2024	001-41802 24876484

Recent 20 filings. View all Neumora Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Neumora Therapeutics, Inc. overview
Neumora Therapeutics, Inc. job
Neumora Therapeutics, Inc. stock
Neumora Therapeutics, Inc. ownership
Neumora Therapeutics, Inc. CEO
Neumora Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.